All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Visomitin
Therapeutic Area: Ophthalmology Product Name: SkQ1
Highest Development Status: Phase III Product Type: Small molecule
Partner/Sponsor/Collaborator: Essex Bio
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 25, 2020
Details:
VISTA-2 is a multi-centre, randomized, double-blind, placebo-controlled clinical study involving two treatment arms: SkQ1 ophthalmic solution and vehicle solution, administered BID.